<DOC>
	<DOCNO>NCT01223742</DOCNO>
	<brief_summary>The aim study evaluate effect exogenous ALC physical mental fatigue mild moderate encephalopatic patient .</brief_summary>
	<brief_title>Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy</brief_title>
	<detailed_description />
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Acetylcarnitine</mesh_term>
	<criteria>1 ) Chronic hepatitis spontaneous manifest HE ( mental state grade 1 2 accord West Haven criterion ) NCTA performance time &gt; 30 second ; 2 ) Hyperammonemia ( venous ammonia concentration &gt; 50 mmol/L ) ; 3 ) Cooperative , hospitalise , adult patient liver cirrhosis diagnose clinical , histological ultrasonographic finding ( reduced dimension liver well splenomegaly ) oesophageal varix stage II III observe endoscopy . 1 ) Major complication portal hypertension , gastrointestinal blood loss , hepatorenal syndrome bacterial peritonitis ; 2 ) Acute superimpose liver injury ; 3 ) Patient neurological disease metabolic disorder , diabetes mellitus , unbalanced heart failure and/or respiratory failure endstage renal disease ; 4 ) Alcoholic toxic cirrhosis toxic brain damage may interfere assessment HE ; 5 ) Severe HE ; 6 ) Administration antiHE medication neomycin , branchedchain amino acid ; 7 ) Any additional precipitating factor high protein intake ( additional highprotein meal ) , constipation intake psycho stimulant , sedative , antidepressant , benzodiazepine , benzodiazepinesantagonists ( flumazenil ) , betaadrenergic blocker , neuromuscular block agent , certain antibiotic ; 8 ) Patients fever , sepsis shock also exclude avoid variation cause body temperature ; 9 ) Illiteracy .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2000</verification_date>
</DOC>